Trial intelligence / Profile preview

Allogeneic Mesenchymal Bone Marrow Cells for Cutaneous Photoaging

NCT01771679Phase 2Unknown

Sponsor
Stemedica Cell Technologies
Start
Jul 2015
Primary completion
Apr 2024
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of allogeneic mesenchymal bone marrow cells in photoaging, sponsored by Stemedica Cell Technologies. Status: unknown.

02

Drugs

allogeneic mesenchymal bone marrow cells
03

Conditions

photoaging

Beyond the preview

Go deeper on NCT01771679.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01771679.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call